C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2006
11/23/2006	CA2608014A1 Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
11/23/2006	CA2608012A1 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
11/22/2006	EP1724268A1 Compound having tgf-beta inhibitory activity and pharmaceutical composition containing same
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724258A1 Heteroarylphenylurea derivative
11/22/2006	EP1723164A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
11/22/2006	EP1723146A1 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
11/22/2006	EP1723144A1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/22/2006	EP1723143A2 Amino cyclopropane carboxamide derivatives as bradykinin antagonists
11/22/2006	EP1723132A1 Ep2 receptor agonists
11/22/2006	EP1723126A2 Novel mch receptor antagonists
11/22/2006	EP1723123A1 Ion channel modulators
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1723121A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
11/22/2006	EP1723116A2 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/22/2006	EP1722863A1 Microcapsules with uv filter activity and process for producing them
11/22/2006	EP1722798A1 Pyrimidine compounds as purine receptor antagonist
11/22/2006	EP1722791A2 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
11/22/2006	EP1722784A2 Ion channel modulators
11/22/2006	EP1722782A2 Compounds, compositions and methods for inhibiting or treating hiv-1
11/22/2006	EP1635817B1 1-phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
11/22/2006	EP1438049B1 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
11/22/2006	EP1343765B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents
11/22/2006	EP1317450B1 Pyrazole compounds useful as protein kinase inhibitors
11/22/2006	EP1301487B1 Viral polymerase inhibitors
11/22/2006	EP1268412B1 Sulphonamido-substituted bridged bicycloalkyl derivatives
11/22/2006	EP1238970B1 Cycloamine ccr5 receptor antagonists
11/22/2006	EP1051176B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
11/22/2006	CN1867567A 1-'(e)-2-(phenyl)ethenyl-4-(arylalkoxy)-oxazole or -thiazole compounds as her-2 tyrosine kinases inhibitors and their use in the treatment of cancer
11/22/2006	CN1867566A Aminopyrones and their use as ATM inhibitors
11/22/2006	CN1867552A Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
11/22/2006	CN1867338A Bicyclic [3.1.0] derivatives as glycine transporter inhibitors
11/22/2006	CN1867334A Quinolinone derivatives as inhibitors of c-fms kinase
11/22/2006	CN1867331A Thalidomide analogs as TNF-alpha modulators
11/22/2006	CN1865248A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
11/22/2006	CN1285588C Farnesyl protein transferase inhibitors
11/22/2006	CN1285580C Pyrimidine compounds
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
11/21/2006	US7138411 Substituted benzopyran derivatives for the treatment of inflammation
11/21/2006	US7138410 Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor
11/21/2006	US7138409 Heterocyclic compounds
11/21/2006	US7138406 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138400 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease
11/21/2006	US7138397 Nitrogenous 5-membered ring compounds
11/21/2006	US7138361 Herbicidal heterocycles
11/21/2006	CA2199226C Process for the preparation of unsymmetrical 4,6-bis(aryloxy)pyrimidine compounds
11/21/2006	CA2158060C Process for the preparation of .beta.-phenylisoserine derivatives
11/21/2006	CA2117413C Herbicidal isoxazole-4-yl-methanone derivatives
11/16/2006	WO2006122072A2 Processes for preparing biaryl ureas and analogs thereof
11/16/2006	WO2006122014A2 Bicyclic derivatives as modulators of ion channels
11/16/2006	WO2006121962A1 N-thiolated 2-oxazolidone antibiotics
11/16/2006	WO2006121218A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	WO2006121106A1 Method for producing indole derivative having piperidine ring
11/16/2006	WO2006120545A1 4' amino linked macrolides useful for the treatment of microbial infections
11/16/2006	WO2006120478A2 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	WO2006120224A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	WO2006119646A1 Compounds and methods for the treatment or prevention of flavivirus infections
11/16/2006	WO2006086705B1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/16/2006	WO2006076415A3 Exo- and diastereo- selective syntheses of himbacine analogs
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	US20060258861 Respiratory or gastrointestinal disorders; cancer
11/16/2006	US20060258860 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258784 New compounds, a process for their preparation and their use as dyes and pigments
11/16/2006	US20060258725 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	US20060258721 neuronal nitric oxide synthase (nNOS) isoform inhibitors; 2-ethyl-1-(1H-indol-5-yl)-isothiourea; neurogenerative disorders, stroke, reperfusion injury, head trauma, migraine headache, neuropathic pain, drug abuse, hyperalgesia
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060258695 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258657 Apoptosis promoters
11/16/2006	US20060258655 Crystalline forms of linezolid intermediate
11/16/2006	US20060258654 Pyridinylmorpholine derivatives
11/16/2006	US20060258653 Derivatives of sulphonamides, their preparation and use as medicaments
11/16/2006	US20060258649 Agronomic pesticide; less toxic; 4-imino-4H-3,1-benzoxazines e.g. N-(2-(3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazol-5-yl)-6-chloro-8-methyl-4H-3,1-benzoxazin-4-ylidene)methanamine
11/16/2006	US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/16/2006	US20060258641 Methods and compositions of novel triazine compounds
11/16/2006	CA2608248A1 Soluble epoxide hydrolase inhibitors and methods of using same
11/16/2006	CA2608184A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
11/16/2006	CA2607917A1 Fungicide 2-pyridyl-methylene-carboxamide derivatives
11/16/2006	CA2607874A1 Quinoline derivatives as neurokinin receptor antagonists
11/16/2006	CA2607670A1 Bicyclic derivatives as modulators of ion channels
11/16/2006	CA2607660A1 N-thiolated 2-oxazolidone antibiotics
11/16/2006	CA2606780A1 Processes for preparing biaryl ureas and analogs thereof
11/16/2006	CA2606507A1 Polymorphic forms of (s)- tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate
11/15/2006	EP1720872A1 Aryl and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of faah enzyme inhibitors
11/15/2006	EP1720868A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
11/15/2006	EP1720866A1 Production method
11/15/2006	EP1720860A1 Triazole compounds and their use as metabotropic glutamate receptor antagonists
11/15/2006	EP1720859A2 Chemokine receptor antagonists
11/15/2006	EP1720844A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
11/15/2006	EP1720839A1 Pyridazinones as antagonists of a4 integrins
11/15/2006	EP1720837A1 Derivatives of n-' (1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity
11/15/2006	EP1720836A1 6-substituted 2,3,4,5-tetrahydro-1h-benzo [d]azepines as 5-ht2c receptor agonists
11/15/2006	EP1720829A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors

1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 647